REGENEREX PHARMA, INC. (RGPX) › Net IncomeREGENEREX PHARMA, INC. (RGPX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2009: -$6.4K2010: -$27.4K2011: -$212.1K2013: -$995.5K2017: -$2.6K2018: -$49.7K2019: -$93.6K2020: $111.6K2021: -$353.8K2022: -$195.6K2023: -$137.3K2024: -$3.54M2025: -$2.53M-$2.53M2009Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$2.53M+28.7%2024-$3.54M-2480.5%2023-$137.3K+29.8%2022-$195.6K+44.7%2021-$353.8K-417.0%2020$111.6K+219.2%2019-$93.6K-88.4%2018-$49.7K-1830.5%2017-$2.6K—2013-$995.5K—2011-$212.1K-674.5%2010-$27.4K-328.7%2009-$6.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share